DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Liabilities | ₹47,594 Cr | ₹37,806 Cr | ₹31,580 Cr | ₹28,470 Cr | ₹25,548 Cr |
What is the latest Total Liabilities ratio of DR REDDYS LABORATORIES ?
Year | Total Liabilities |
---|---|
Mar2025 | ₹47,594 Cr |
Mar2024 | ₹37,806 Cr |
Mar2023 | ₹31,580 Cr |
Mar2022 | ₹28,470 Cr |
Mar2021 | ₹25,548 Cr |
How is Total Liabilities of DR REDDYS LABORATORIES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹47,594 Cr | 25.89 | |
Mar2024 | ₹37,806 Cr | 19.72 | |
Mar2023 | ₹31,580 Cr | 10.92 | |
Mar2022 | ₹28,470 Cr | 11.44 | |
Mar2021 | ₹25,548 Cr | - |
Compare Total Liabilities of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹106,628.5 Cr | 1.4% | -3.3% | -7.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,551.0 Cr | 0.4% | 1.8% | 4.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,704.0 Cr | -1.1% | 0.1% | 45.6% | Stock Analytics | |
CIPLA | ₹123,675.0 Cr | 3.8% | 1.2% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,925.0 Cr | 2.2% | 11.7% | 11.7% | Stock Analytics | |
MANKIND PHARMA | ₹107,363.0 Cr | -1.7% | 13% | 22.9% | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | 1.4% |
-3.3% |
-7.2% |
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses